# A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities

> clinical trial · VERIFIED · 2026-07-30

Status: RECRUITING · Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Condition: Non-small Lung Cancer

- Company: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- Sector: Non-small Lung Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07308106

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.